HIGHLIGHTS
- who: Guang-Tan Lin and colleagues from the Sichuan University, China have published the paper: Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer, in the Journal: Nutritional support
- how: In this study TRG grade 1a/1b/2 was considered tumor remission (TR) and the TRG3 grade was considered non-tumor remission (non-TR). exploration after neoadjuvant therapy) and with history of gastrectomy or endoscopic submucosal dissection. The results can be a significant reference for patients using this regimen. Third although immune-related adverse events were recorded separately in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.